1st Biotherapeutics

Risk score

57

Headquarters

Flag of South KoreaSouth Korea

1STBIO is committed to developing revolutionary treatments with a primary focus on delivering new drugs to patients. Our main efforts are directed towards the exploration and creation of innovative first-of-its-kind therapeutic candidates with a high probability of success in clinical applications. Currently, 1STBIO employs a team of 24 professionals specializing in biochemistry, drug chemistry, pharmacology, and corporate growth. We operate as a specialized team in the field of drug discovery and development, and we have strong connections with research and development networks in academia, medical institutions, industry, CROs, and investors in Korea, China, and the United States.